2009 Speakers


Margaret Anderson
Executive Director, FasterCures

Jana Armstrong
Executive Director, Drugs for Neglected Diseases initiative North America

Mara G. Aspinall
President and CEO, On-Q-Ity

Christopher P. Austin, M.D.
Director, NIH Chemical Genomics Center


Dana Ball
Program Director, The Leona M. & Harry B. Helmsley Charitable Trust

Alex Barkas
Managing Director, Prospect Venture Partners

Robert J. Beall, Ph.D.
President and CEO, Cystic Fibrosis Foundation

Sharon Begley
Senior Editor, Newsweek

Melanie Schnoll Begun
Managing Director, Morgan Stanley Smith Barney Philanthropic Services

Peter H. Bell
Executive Vice President, Programs and Services Autism Speaks

Edward J. Benz, Jr. M.D.
President and CEO, Dana-Farber Cancer Institute

Melissa A. Berman
President and CEO, Rockefeller Philanthropy Advisors, Inc.

Lucy Bernholz
Founder and President, Blueprint Research & Design, Inc

Seth Berkley, M.D.
President and CEO, International AIDS Vaccine Initiative

Debra Black
Founder and Chair, Melanoma Research Alliance

Robert Blum
President and CEO, Cytokinetics, Inc.

Robi Blumenstein
President, CHDI Management/CHDI Foundation

Russell Bromley
Chief Operating Officer, Myelin Repair Foundation

Debi Brooks
Co-Founder, Michael J. Fox Foundation

G. Steven Burrill
CEO, Burrill & Company


Randall L. Carpenter, M.D.
Co-Founder, President and Chief Executive Officer, Seaside Therapeutics

Gail H. Cassell, Ph.D.
Vice President, Scientific Affairs and Distinguished Lilly Research Scholar, Infectious Diseases, Eli Lilly and Company

Frank Casty, M.D., FACP, FCCP 
Vice President, External Medical Relations and Vice President, Technical Evaluation, U.S. Business Development of AstraZeneca PLC

Ceci Connolly
Staff Writer, Washington Post


Wendy Diller
Co-Chief, Business Bureau, Biopharma Group Elsevier Business Intelligence

Mary Dwight
Vice President of Government Affairs, Cystic Fibrosis Foundation


Christopher D. Earl, Ph.D.
Former CEO, BIO Ventures for Global Health


Joan Flax
Board of Advisors, California Pizza Kitchen

Larry Flax
Co-CEO and Co-Chairman of the Board, California Pizza Kitchen

Stephen H. Friend, M.D., Ph.D.
President, CEO and a Co-Founder, Sage Bionetworks


Levi Garraway M.D., Ph.D.
Department of Medical Oncology, Dana-Farber Cancer Institute
Associate Physician, Brigham and Women's Hospital

James Geraghty
Senior Vice President, Genzyme Corp.

Kathy Giusti
Founder and CEO, Multiple Myeloma Research Consortium

George Golumbeski
Senior Vice President, Business Development, Celgene

William Greene, M.D.
Managing Director, Genentech

The Hon. James Greenwood
President and CEO, Biotechnology Industry Organization


Haroon Hashmi
Director, Drug Development in Asia-Pacific, Biogen Idec

Jamie Heywood
Co-Founder, PatientsLikeMe

Katie Hood
CEO, The Michael J. Fox Foundation for Parkinson's Research


Susan L. Kelley, M.D.
Chief Medical Officer, Multiple Myeloma Research Foundation

Hannah E. Kettler, Ph.D.
Economist and Senior Program Officer, Global Health Advocacy, Bill & Melinda Gates Foundation

Jeffrey Kindler
Chief Executive Officer and Chairman of the Board, Pfizer


Alan J. Lewis, Ph.D.
President and CEO, Juvenile Diabetes Research Foundation

Brian Loew
Founder and CEO, Inspire

Christian Loucq
Director, PATH Malaria Vaccine Initiative

Susan Love, M.D.
President, Dr. Susan Love Research Foundation


Amy Dockser Marcus
Staff Reporter, The Wall Street Journal

Vicki Seyfert-Margolis
Adviser, U.S. Food and Drug Administration

Shmuel Meitar
Co-Founder and Principal, Aurec Group

Douglas A. Melton, Ph.D.
Co-Director, Harvard Stem Cell Institute and Howard Hughes Medical Institute Investigator

Michael Milken
Chairman, FasterCures; Chairman, The Milken Institute

Melinda Moree
Interim CEO, BIO Ventures for Global Health


Patrick Nef, Ph.D.
Executive Vice-President of Business Development, Medicines for Malaria Venture

Garry Neil, M.D.
Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson


Fredric Pashkow
Executive Vice President and Chief Medical Officer, Cardax Pharmaceuticals

Stuart Peltz
President and Chief Executive Officer, PTC Therapeutics, Inc.

John Perkins 
Senior Vice President and General Manager, Portfolio Management and U.S. Business

Steve Perrin, Ph.D.
Chief Executive Officer & Chief Scientific Officer, ALS Therapy Development Institute

Kyle Peterson
Managing Director, FSG Social Impact Advisors

Mike Powell, Ph.D.
General Partner, Sofinnova Ventures

Dennis Purcell
Senior Managing Director of Fund I and Fund II, Aisling Capital


Amy Comstock Rick
Chief Executive Officer, Parkinson's Action Network


Richard Seabrook, Ph.D., MBA
Head of Business Development, Wellcome Trust

Marie Schiller
Partner, Health Advances

Joshua M. Sharfstein, M.D.
Principal Deputy Commissioner, Food and Drug Administration

Robert H. Shelton
Co-Founder, Chairman & CEO, Private Access

Gregory C. Simon
Senior Vice President, Worldwide Policy, Pfizer

Jonathan W. Simons, M.D.
President and CEO, Prostate Cancer Foundation

Kathryn Smith
Managing Director, FastForward

Susan Solomon
Chief Executive Officer and Co-Founder, The New York Stem Cell Foundation

Howard R. Soule, Ph.D.
Executive Vice President, Discovery and Translation, Chief Science Officer, Prostate Cancer Foundation

Ken Stuart
President and Director, Seattle Biomedical Research Institute


Rudolph Tanzi, Ph.D.
Professor of Neurology, Massachusetts General Hospital

The Hon. Billy Tauzin
President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)

Elizabeth Thompson
Vice President, Health Sciences, Susan G. Komen for the Cure


Steve Usdin
Washington Editor, BioCentury


John Walsh
CEO, Alpha-1 Foundation

Tim Walter
CEO/Executive Director, Association of Small Foundations

David Wholley
Director, Biomarkers Consortium at the Foundation for the National Institutes of Health

Greg Wiederrecht
Vice President & Head, External Scientific Affairs Worldwide Licensing & External Research Merck & Co., Inc.

Robert Wills, Ph.D.
Vice President, Alliance Management, Johnson & Johnson

Anne Wojcicki
Co-Founder and President, 23andMe